Variable | Focal seizures (FS) | Focal sensory seizures (FSS) | Focal motor seizures (FMS) | Focal seizures with impaired awareness (FSIA) | Focal to bilateral tonic-clonic seizures (FBTCS) | NHS3 |
---|---|---|---|---|---|---|
Somatization (SCL-90) | − 0.029 | − 0.111 | − 0.044 | 0.000 | − 0.039 | 0.137 |
Obsession (SCL-90) | − 0.024 | − 0.035 | 0.031 | 0.065 | − 0.112 | 0.069 |
Interpersonal sensitivity (SCL-90) | 0.025 | − 0.004 | 0.042 | 0.164 | − 0.064 | 0.150 |
Depression (SCL-90) | 0.065 | 0.057 | 0.106 | − 0.023 | − 0.043 | − 0.016 |
Anxiety (SCL-90) | − 0.027 | − 0.043 | 0.004 | 0.010 | − 0.147 | 0.169 |
Hostility (SCL-90) | 0.138 | 0.196 | | 0.007 | 0.016 | 0.082 |
Phobic anxiety (SCL-90) | − 0.160 | − 0.144 | − 0.128 | − 0.077 | − 0.128 | − 0.069 |
Paranoid ideations (SCL-90) | − 0.086 | − 0.071 | 0.000 | 0.087 | − 0.064 | 0.119 |
Psychoticism (SCL-90) | − 0.107 | − 0.126 | − 0.047 | − 0.028 | − 0.088 | 0.086 |
Variable | T-lymph. | CD3+CD4+ | CD3+CD8+ | T-NK | B-lymph. | NK | CD4/CD8 ratio |
---|---|---|---|---|---|---|---|
Somatization (SCL-90) | − 0.612 | − 0.099 | − 0.291 | − 0.313 | | − 0.122 | 0.209 |
Obsessions (SCL-90) | − 0.128 | 0.529 | − 0.735 | − 0.424 | 0.107 | 0.218 | |
Interpersonal sensitivity (SCL-90) | 0.249 | | − 0.032 | − 0.152 | − 0.133 | | |
Depression (SCL-90) | − 0.307 | 0.493 | − 0.409 | 0.417 | 0.088 | | |
Anxiety (SCL-90) | − 0.241 | 0.197 | − 0.429 | − 0.109 | 0.496 | − 0.144 | |
Aggression (SCL-90) | − 0.303 | 0.637 | − 0.515 | 0.115 | 0.432 | | |
Phobic anxiety (SCL-90) | − 0.433 | 0.241 | − 0.625 | − 0.262 | 0.441 | 0.194 | |
Paranoid ideations (SCL-90) | − 0.074 | 0.659 | − 0.265 | 0.218 | − 0.023 | | |
Psychoticism (SCL-90) | − 0.207 | 0.682 | − 0.518 | 0.459 | 0.074 | |
Variable | Focal seizures (FS) | Focal sensory seizures (FSS) | Focal motor seizures (FMS) | Focal seizures with impaired awareness (FSIA) | Focal to bilateral tonic-clonic seizures (FBTCS) | NHS3 |
---|---|---|---|---|---|---|
Somatization (SCL-90) | 0.069 | 0.074 | − 0.350 | 0.406 | 0.444 | 0.669 |
Obsession (SCL-90) | − 0.110 | − 0.116 | − 0.093 | | | 0.651 |
Interpersonal sensitivity (SCL-90) | − 0.708 | − 0.710 | 0.733 | 0.426 | 0.444 | 0.620 |
Depression (SCL-90) | − 0.403 | − 0.398 | 0.158 | | | |
Anxiety (SCL-90) | − 0.071 | − 0.080 | − 0.015 | | | |
Aggression (SCL-90) | − 0.528 | − 0.521 | 0.024 | 0.686 | 0.616 | 0.662 |
Phobic anxiety (SCL-90) | − 0.337 | − 0.336 | − 0.041 | | | |
Paranoid ideations (SCL-90) | − 0.412 | − 0.416 | 0.287 | | | |
Psychoticism (SCL-90) | − 0.470 | − 0.459 | 0.356 | 0.749 | 0.690 | |
Variable | Left-handers | Right-handers | Significance |
---|---|---|---|
Focal seizures (FS) | 154.71 ± 272.51 | 18.41 ± 46.91 | |
Focal sensory seizures (FSS) | 150.00 ± 275.38 | 15.44 ± 45.72 | |
Focal motor seizures (FMS) | 11.86 ± 20.55 | 7.66 ± 40.21 | n.s. |
Focal seizures with impaired awareness (FSIA) | 8.71 ± 22.62 | 14.65 ± 36.86 | n.s. |
Focal to bilateral tonic-clonic seizures (FBTCS) | 9.57 ± 17.48 | 14.98 ± 22.39 | n.s. |
NHS3 | 16.71 ± 12.78 | 13.15 ± 8.67 | n.s. |
T-lymphocytes | 77.63 ± 5.19 | 73.97 ± 6.60 | n.s. |
T-helpers CD3+CD4 | 46.59 ± 8.94 | 46.59 ± 6.71 | n.s. |
T-cytotoxic (CD3+CD8+) | 28.87 ± 7.51 | 25.62 ± 6.22 | n.s. |
T-NK (CD3+CD16+CD56+) | 9.29 ± 5.91 | 6.01 ± 4.16 | n.s. |
B-lymphocytes (CD3+CD19+) | 10.24 ± 3.02 | 12.62 ± 4.97 | n.s. |
Natural Killers (CD3-CD16+CD+56) | 9.81 ± 3.20 | 11.69 ± 5.69 | n.s. |
Regulatory index (CD4/CD8) ratio | 1.79 ± 0.79 | 1.97 ± 0.65 | n.s. |
Variable | Left-handed Patients (N = 7) | Right-handed Patients (N = 59) | Significance |
---|---|---|---|
Somatization SCL-90) | 5.57 ± 3.69 | 7.15 ± 6.18 | N.S. |
Obsession (SCL-90) | 6.14 ± 4.45 | 8.34 ± 6.47 | N.S. |
Sensitivity (SCL-90) | | | |
Depression (SCL-90) | 6.14 ± 5.55 | 9.47 ± 8.68 | N.S. |
Anxiety (SCL-90) | 5.00 ± 2.65 | 5.59 ± 6.01 | N.S. |
Aggression (SCL-90) | 2.86 ± 2.67 | 5.14 ± 4.33 | N.S. |
Phobia (SCL-90) | 1.43 ± 2.07 | 3.45 ± 3.98 | N.S. |
Paranoid (SCL-90) | 3.00 ± 3.06 | 4.00 ± 3.80 | N.S. |
Psychoticism (SCL-90) | 2.57 ± 2.64 | 3.40 ± 4.30 | N.S. |
Total Score (SCL-90) | 37.43 ± 23.96 | 46.47 ± 31.47 | N.S. |
Variable | T-lymph. | CD3+CD4+ | CD3+CD8+ | T-NK | B-lymph. | NK | CD4/CD8 ratio |
---|---|---|---|---|---|---|---|
Somatization (SCL-90) | − 0.209 | − 0.089 | − 0.109 | − 0.063 | − 0.020 | 0.169 | 0.040 |
Obsessions (SCL-90) | − 0.228 | 0.000 | − 0.232 | − 0.078 | − 0.010 | 0.175 | 0.182 |
Interpersonal sensitivity (SCL-90) | − 0.169 | − 0.006 | − 0.141 | − 0.105 | − 0.090 | 0.173 | 0.145 |
Depression (SCL-90) | − 0.169 | − 0.045 | − 0.108 | − 0.159 | − 0.023 | 0.123 | 0.085 |
Anxiety (SCL-90) | − 0.172 | − 0.112 | − 0.023 | − 0.153 | − 0.026 | 0.124 | − 0.023 |
Aggression (SCL-90) | − 0.119 | 0.074 | − 0.184 | − 0.202 | 0.063 | 0.061 | 0.195 |
Phobic anxiety (SCL-90) | − 0.043 | 0.095 | − 0.188 | − 0.211 | 0.006 | − 0.027 | 0.187 |
Paranoid ideations (SCL-90) | − 0.208 | − 0.006 | − 0.187 | − 0.058 | − 0.070 | 0.185 | 0.154 |
Psychoticism (SCL-90) | − 0.043 | − 0.199 | − 0.213 | − 0.021 | 0.244 | 0.104 |